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RESEARCH ARTICLE

Daptomycin-Resistant Enterococcus faecalis Diverts the Antibiotic
Molecule from the Division Septum and Remodels Cell Membrane
Phospholipids
Truc T. Tran,a,b Diana Panesso,a,c Nagendra N. Mishra,d Eugenia Mileykovskaya,e Ziqianq Guan,f Jose M. Munita,a,g Jinnethe Reyes,a,c
Lorena Diaz,a,c George M. Weinstock,h Barbara E. Murray,a,i Yousif Shamoo,j,k William Dowhan,e Arnold S. Bayer,d,l Cesar A. Ariasa,c,i
Division of Infectious Diseases, Department of Internal Medicine, University of Texas Medical School at Houston, Houston, Texas, USAa; University of Houston, College of
Pharmacy, Houston, Texas, USAb; Molecular Genetics and Antimicrobial Resistance Unit, Universidad El Bosque, Bogota, Colombiac; Los Angeles Biomedical Research
Institute at Harbor-University of California Los Angeles Medical Center, Torrance, California, USAd; Department of Biochemistry and Molecular Biology, University of Texas
Medical School at Houston, Houston, Texas, USAe; Department of Biochemistry, Duke University Medical Center, Durham, North Carolina, USAf; Clinica Alemana de
Santiago and Universidad del Desarrollo, Santiago, Chileg; The Genome Institute, Washington University, St. Louis, Missouri, USAh; Department of Microbiology and
Molecular Genetics, University of Texas Medical School at Houston, Texas, USAi; Department of Biochemistry and Cell Biology, Rice University, Houston, Texas, USAj;
Department of Ecology and Evolutionary Biology, Rice University, Houston, Texas, USAk; David Geffen School of Medicine, University of California Los Angeles, Los
Angeles, California, USAl

ABSTRACT Treatment of multidrug-resistant enterococci has become a challenging clinical problem in hospitals around the
world due to the lack of reliable therapeutic options. Daptomycin (DAP), a cell membrane-targeting cationic antimicrobial lipopeptide, is the only antibiotic with in vitro bactericidal activity against vancomycin-resistant enterococci (VRE). However, the
clinical use of DAP against VRE is threatened by emergence of resistance during therapy, but the mechanisms leading to DAP
resistance are not fully understood. The mechanism of action of DAP involves interactions with the cell membrane in a calciumdependent manner, mainly at the level of the bacterial septum. Previously, we demonstrated that development of DAP resistance
in vancomycin-resistant Enterococcus faecalis is associated with mutations in genes encoding proteins with two main functions,
(i) control of the cell envelope stress response to antibiotics and antimicrobial peptides (LiaFSR system) and (ii) cell membrane
phospholipid metabolism (glycerophosphoryl diester phosphodiesterase and cardiolipin synthase). In this work, we show that
these VRE can resist DAP-elicited cell membrane damage by diverting the antibiotic away from its principal target (division septum) to other distinct cell membrane regions. DAP septal diversion by DAP-resistant E. faecalis is mediated by initial redistribution of cell membrane cardiolipin-rich microdomains associated with a single amino acid deletion within the transmembrane
protein LiaF (a member of a three-component regulatory system [LiaFSR] involved in cell envelope homeostasis). Full expression of DAP resistance requires additional mutations in enzymes (glycerophosphoryl diester phosphodiesterase and cardiolipin
synthase) that alter cell membrane phospholipid content. Our findings describe a novel mechanism of bacterial resistance to
cationic antimicrobial peptides.
IMPORTANCE The emergence of antibiotic resistance in bacterial pathogens is a threat to public health. Understanding the
mechanisms of resistance is of crucial importance to develop new strategies to combat multidrug-resistant microorganisms.
Vancomycin-resistant enterococci (VRE) are one of the most recalcitrant hospital-associated pathogens against which new therapies are urgently needed. Daptomycin (DAP) is a calcium-decorated antimicrobial lipopeptide whose target is the bacterial cell
membrane. A current paradigm suggests that Gram-positive bacteria become resistant to cationic antimicrobial peptides via an
electrostatic repulsion of the antibiotic molecule from a more positively charged cell surface. In this work, we provide evidence
that VRE use a novel strategy to avoid DAP-elicited killing. Instead of “repelling” the antibiotic from the cell surface, VRE diverts the antibiotic molecule from the septum and “traps” it in distinct membrane regions. We provide genetic and biochemical
bases responsible for the mechanism of resistance and disclose new targets for potential antimicrobial development.
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T

he emergence of antibiotic resistance in health care-associated
pathogens is recognized as a major public health threat by the
World Health Organization (1). Vancomycin-resistant entero-
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cocci (VRE) are prime examples of such multidrug-resistant organisms, against which new therapies are urgently needed (2).
Daptomycin (DAP) is a cyclic antimicrobial lipopeptide that has
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TABLE 1 Daptomycin-susceptible and -resistant Enterococcus faecalis strains and derivatives
MIC (g/ml) of DAP

Predicted amino acid change
Clsc

LiaFd

GdpDe

None
Deletion of Ile
at position 177
Deletion of Ile
at position 177
None

None
Deletion of Ile
at position 170
None

BHI

TSB

MIC (g/ml) of
DAP-BDPb

0.5
8

3
64

2
64

8
32

S613⌬liaF177

3

16

16

16

None
Deletion of Lys
at position 61
None

S613⌬gdpD170

0.75

3

2

8

None

S613⌬liaF177gdpD170

3

24

16

16

None

S613⌬liaF177gdpD170cls61

6

64

64

32

Deletion of Lys
at position 61

Enterococcus faecalis strain

MH

S613
R712

a

a

a

Deletion of Ile
at position 177
Deletion of Ile
at position 177

Deletion of Ile
at position 170
Deletion of Ile
at position 170
Deletion of Ile
at position 170

a

The MIC of daptomycin was determined by the use of Etest (bioMérieux) on the indicated medium.
The MIC of BODIPY-labeled daptomycin (BDP-DAP) was determined by broth microdilution.
c Cls, cardiolipin synthase.
d LiaF, lipid II-interacting-antibiotic protein.
e GdpD, glycerophosphoryl diester phosphodiesterase.
b

become a key frontline drug against VRE due to its potent in vitro
bactericidal activity. However, an important emerging clinical
problem is the development of DAP resistance during therapy (3,
4). DAP is heavily calcium complexed, an event which is absolutely required for its antimicrobial effect becoming a de facto
cationic antimicrobial peptide (5). Recent data using fluorescence
microscopy in a Bacillus subtilis model (6) indicate that the mechanism of action of DAP involves insertion of the antibiotic molecule into the bacterial membrane in a calcium-dependent manner
with a strong preference for interactions with the bacterial division septum. Binding of the antibiotic produces membrane distortions that alter the morphology of the cell and recruit proteins
essential for cell division. The defects in cell membrane and cell
wall synthesis cause damages in cell integrity that lead to cell death
(6). Additionally, a crucial step in the mechanism of DAPmediated disruption of the cell membrane appears to be the ability
of the antibiotic to oligomerize within the cell membrane, a phenomenon that seems to be dependent on the presence of the negatively charged phospholipid phosphatidylglycerol (PG) (5).
Although the mechanisms of DAP resistance have not been
fully elucidated, a correlation with evolution of a more relatively
positive surface charge has been observed in Staphylococcus aureus
(7–9). Electrostatic “repulsion” between relatively positively
charged cell surfaces and the calcium-DAP molecule complex is
believed to prevent initial interaction of DAP with the cell membrane. Our initial genomic studies in a pair of clinical strains of
vancomycin-resistant Enterococcus faecalis recovered from the
bloodstream of a patient before and after DAP therapy indicated
that the mechanism of resistance was associated with mutations in
two groups of genes. The first group of genes, liaFSR, encodes a
three-component regulatory system that is involved in cell envelope homeostasis (10). Using an allelic replacement strategy, we
showed that deletion of isoleucine in position 177 of the putative
LiaF (lipid II-interacting-antibiotic protein) was sufficient to decrease DAP susceptibility (although still below the clinical breakpoint) and led to DAP tolerance, abolishing the in vitro bactericidal activity of the antibiotic (11). Supporting the important role
of the LiaFSR system in development of DAP resistance, we found
that mutations in liaFSR were commonly observed in DAPresistant isolates of Enterococcus faecium (12, 13). A second group
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of genes that seem to be involved in DAP resistance in enterococci
are ones encoding enzymes catalyzing reactions implicated in cell
membrane phospholipid metabolism (glycerophosphoryl diester
phosphodiesterase [GdpD] and cardiolipin synthase [Cls]) (12).
Indeed, we previously showed that in vivo development of DAP
resistance in enterococci is associated with important changes in
cell membrane phospholipid composition (14). Moreover, an important decrease in PG plus a surprising increase in negatively
charged phospholipid content (but not in positively charged species as previously described in S. aureus [7, 9]) was observed in
DAP-resistant derivatives of both E. faecalis and E. faecium (14)
isolated from patients after DAP therapy, suggesting that a more
positive surface charge was not the main mediator of DAP resistance in enterococci.
In this study, we demonstrate that the emergence of DAP nonsusceptibility in vancomycin-resistant E. faecalis is associated with
an initial cell membrane cardiolipin microdomain redistribution
caused by an amino acid deletion in LiaF that diverts the antibiotic
away from the division septum, a critical and vital structure for cell
survival. The mechanism is completed by changes in phospholipid
content brought about by alterations in enzymes involved in
phospholipid metabolism. Our work offers novel insights into the
mechanisms of bacterial resistance against the attack by antimicrobial peptides and provides potential new targets for antimicrobial development.
RESULTS

Daptomycin resistance is associated with exclusion of BDPDAP from the division septum. In order to understand the mechanism of enterococcal daptomycin (DAP) resistance, we used a
previously described clinically derived pair of E. faecalis strains, a
vancomycin-resistant DAP-susceptible (Daps) strain and a DAPresistant (Dapr) strain recovered from the bloodstream of a patient before and after DAP therapy (S613 and R712, respectively
[Table 1]) (12). We initially examined the binding of DAP to the
cell membrane of the Daps clinical strain, S613, versus its Dapr
variant, R712. We used boron-dipyrromethene (BODIPY)labeled DAP (BDP-DAP), a fluorescent derivative of DAP that
retains antimicrobial activity (MICs of 8 and 32 g/ml for strain
S613 and R712, respectively) (Table 1), to visualize DAP interac-

July/August 2013 Volume 4 Issue 4 e00281-13

Daptomycin Resistance in Enterococcus faecalis

FIG 1 BODIPY-labeled daptomycin (BDP-DAP) staining of representative E. faecalis S613 (DAP-susceptible) (a to e) and R712 (DAP-resistant) (f to j) cells at
increasing concentrations of the fluorescent antibiotic. The images within each panel show bacterial cells captured by fluorescence (top image) and phasecontrast microscopy (bottom image) (bars, 1 m). (a and b) In E. faecalis S613, binding of the antibiotic in a “peppering” pattern is observed only at subinhibitory
concentrations of BDP-DAP. (c to e) At higher BDP-DAP concentrations, saturation of the surface is observed with staining of the division septum (white
arrows). (f to j) In E. faecalis R712, the “peppering” staining pattern and binding of the fluorescent antibiotic is observed at all concentrations without
visualization of septa. Additional images selected from different microscopic fields are shown in Fig. S2 in the supplemental material.

tions with the cell membrane. Figure 1a and b show that at subinhibitory concentrations, multiple foci of BDP-DAP were bound to
the S613 cell membrane and were distributed throughout the cell
(“peppering” pattern) but sparing the division septum. At concentrations at and above the MIC, BDP-DAP decorated the
E. faecalis S613 cell envelope in a homogeneous pattern, with a
clear preference for the division septum (Fig. 1c to e). Indeed, ca.
85% of cells in a microscopic field displayed a linear fluorescence
pattern at the septa (108 cells examined, BDP-DAP concentration
of 16 g/ml) (see Fig. S2 in the supplemental material). The binding pattern of BDP-DAP to Dapr strain R712 was similar to that of
strain S613 at low concentrations (Fig. 1f and g). Moreover, we
were able to observe consistent binding of BDP-DAP to E. faecalis
R712 at all concentrations tested (Fig. 1f to j). However, at increasingly higher BDP-DAP concentrations, R712 continued to exhibit
the “peppering” pattern. Notably, this pattern excluded the midpoints of the cells where the main septal structures are localized
(Fig. 1h to j). Even at 16 and 32 g/ml, only a small proportion of
R712 cells exhibited septal staining with BDP-DAP compared to
S613 cells (20% [n ⫽ 104] and 49% [n ⫽ 110], respectively; P ⬍
0.0001) (Fig. S2). To further confirm that septal exclusion of BDPDAP from septa is critical in the mechanism of resistance, we
quantitated the fluorescence intensity in S613 and R712 cells
treated with increasing concentrations of BDP-DAP and normalized to protein contents of the samples. No differences in fluorescent intensities between S613 and R712 cells were observed at any
of the BDP-DAP concentrations tested (2 to 32 g/ml) (all P ⬎
0.05) (Fig. S3), suggesting that the total amount of bound antibiotic was similar in S613 and R712 cells. These data suggest that
exclusion of DAP from the main septal structures and diversion of
the antibiotic to other sites of the cell membrane mediate, at least
in part, DAP resistance in E. faecalis R712.

July/August 2013 Volume 4 Issue 4 e00281-13

Diversion of BDP-DAP away from septa is mediated by a mutation in liaF. Our previous genomic studies comparing E. faecalis
S613 to R712 indicated that DAP resistance was associated with
the following amino acid changes: (i) deletion of Ile at position
177 of LiaF (LiaF⌬177), a member of a three-component regulatory
system (LiaFSR) involved in cell envelope homeostasis, (ii) deletion of Ile at position 170 of GdpD (GdpD⌬170), a putative glycerophosphoryl diester phosphodiesterase that is likely involved in
hydrolyzing deacylated phospholipids (PLs), and (iii) deletion of
Lys at position 61 (Cls⌬61) of a cardiolipin (CL) synthase (Cls)
enzyme. Using an allelic replacement strategy, we then sequentially introduced the resistance-associated alleles belonging to
strain R712 into strain S613 and found that LiaF⌬177 was a pivotal
event in development of DAP resistance (12). Indeed, introduction of the resistant liaF allele alone to Daps S613 (S613⌬liaF177)
decreased DAP susceptibility (12). Here, we show that
S613⌬liaF177 resulted in the exclusion of BDP-DAP from septal
structures and the “peppering pattern” at higher BDP-DAP concentrations (8 g/ml) than seen in S613 (4 g/ml [Fig. 2a]). At
16 g/ml, homogeneous staining of the cell surface of strain
S613⌬liaF177 and visualization of septal DAP accumulation in a
linear pattern was evident, as seen with S613 at concentrations
ⱖ8 g/ml (Fig. 2a; see Fig. S4 in the supplemental material).
We subsequently evaluated the binding pattern of BDP-DAP
in an E. faecalis S613 derivative carrying both resistance-associated
liaF and gdpD alleles from E. faecalis R712 (S613⌬liaF177gdpD170). As
shown in Fig. 2b, no difference in the pattern of BDP-DAP staining in strain S613⌬liaF177gdpD170 compared to S613⌬liaF177 was
noted, suggesting that the contribution of the GdpD alteration to
diversion of DAP from the septum was minimal. This is consistent
with our analysis of S613⌬gdpD170, a derivative of S613 carrying
GdpD⌬170, whose pattern of BDP-DAP binding was identical to
®
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FIG 2 BODIPY-labeled DAP (BDP-DAP) staining of representative cells from E. faecalis S613 derivatives at increasing concentrations of the fluorescent
antibiotic. The images for each BDP-DAP concentration (from 2 to 32 g/ml) and strain show bacterial cells captured by fluorescence (top image) and
phase-contrast (bottom image) microscopy (bars, 1 m). (a) E. faecalis S613⌬liaF177 is a derivative of strain S613 carrying a mutated liaF belonging to E. faecalis
R712 (daptomycin resistant). (b) S613⌬liaF177gdpD170 is a derivative of S613 carrying both liaF and gdpD alleles from strain R712. (c) S613⌬liaF177gdpD170cls61 carries
mutated liaF, gdpD, and cls alleles from R712. Introduction of the three mutated alleles prevents BDP-DAP interaction with the septum up to concentrations of
16 g/ml of BDP-DAP. Additional images selected from different microscopic fields are shown in Fig. S3 in the supplemental material. Arrows indicate
visualization of septum in a linear pattern.

that of S613 (data not shown). We next created a derivative of
S613 carrying all three of the resistance-associated alleles
(S613⌬liaF177gdpD170cls61) and found that S613⌬liaF177gdpD170cls61 excluded BDP-DAP from septal regions and also displayed the “peppering pattern” at even higher BDP-DAP concentrations (up to
16 g/ml), similar to R712 (Fig. 2c; see Fig. S4 in the supplemental
material). Thus, our findings indicate that DAP resistance involves antibiotic diversion from the septum, initially mediated by
a mutation in liaF and ultimately completed by concomitant mutations of other enzymes involved in PL metabolism (i.e., GdpD
and Cls). Of note, we were unable to introduce the mutated cls
allele alone in S613, S613⌬liaF177, or S613⌬gdpD170 (after multiple
attempts), suggesting that the isolated Lys61 deletion in the putative Cls enzyme may be deleterious unless other changes in cell
membrane homeostasis brought about simultaneously by LiaF
and GdpD have occurred.
DAP resistance involves redistribution of cardiolipin microdomains away from the division septum. The hydrophobic
fluorescent dye 10-N-nonyl-acridine orange (NAO) has been
used previously to visualize CL-enriched domains in Escherichia
coli (15, 16) and B. subtilis (17, 18). The association of NAO with
CL (but not other PLs) induces a green-to-red shift in its fluorescence emission attributed to the ability of CL (harboring four
chains and a small head group) to make microdomains (arrays)
within the cell membrane (19, 20). This configuration provides
NAO with enough space to form arrays of parallel stacks between
the CL arrays (15, 19). As shown in Fig. 3a, visualization of Daps
E. faecalis S613 stained with NAO (500 nm) revealed CL-rich domains during early stationary phase of growth. These microdomains were visualized as intense linear staining at the site of the
bacterial septum and as polar spots (Fig. 3a), in agreement with
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previous data generated in E. coli and B. subtilis (15–18). The
NAO-stained domains were also visualized under red fluorescence (see Fig. S5 in the supplemental material), indicating that
the microdomains consist of CL arrays. Additionally, NAO
(500 nm) did not affect the growth of E. faecalis S613. Important
changes in CL domain distribution were observed in E. faecalis
R712 compared to S613 (Fig. 3b), featuring markedly reduced
linear NAO fluorescence at sites of cell division (i.e., linear septal
fluorescence was observed in only 37% of R712 cells [n ⫽ 65],
compared to 82% of S613 cells [n ⫽ 56]; P ⬍ 0.001). Instead, we
observed intense spots of NAO fluorescence (without a linear pattern) with some staining localized at potential sites of cell division
(Fig. 3b and Fig. S6); these observations are consistent with the
notion that CL domain redistribution is a major mediator of DAP
resistance. Using transmission electron microscopy (TEM), we
previously showed that R712 (Dapr) harbors a plethora of aberrant septal structures (12). Here, also using TEM, we were able to
determine that separation of individual R712 cells was infrequently observed in R712, compared to S613. Indeed, R712 had a
significantly higher number of multicell aggregates (⬎4 cells) than
parental S613 (57 versus 16 in 100 cells; P ⬍ 0.0001) (Fig. S7). This
is consistent with alterations in the ability of these enterococcal
cells to fully divide and separate, in association with DAP resistance. Thus, our data suggest that redistribution of CL arrays severely affects cell division machinery. In agreement with this hypothesis, anionic PLs have been proposed to mediate the
organization of cell division proteins at specific sites of the cell
membrane (CM) (21).
Figure 3c and Fig. S6 in the supplemental material show that
LiaF⌬177 was sufficient to alter the distribution of CL microdomains, since NAO staining of strain S613⌬liaF177 was similar to
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FIG 3 Staining of representative cells from E. faecalis S613 (DAP susceptible), R712 (DAP resistant), and S613 derivatives with 10-N-nonyl-acridine orange
(NAO) at 500 nM revealing cardiolipin-rich domains in the cell membrane. The top images in panels show bacterial cells captured with a fluorescent microscope
(bars, 1 m). The bottom images in panels are phase-contrast images of the same bacterial cells. (a and d) In E. faecalis S613 and S613⌬gdpD170, CL-enriched
domains are visualized at the poles and division septa. (b) CL-enriched domain redistribution is observed in DAP-resistant E. faecalis R712. (c) Introduction of
a mutated liaF allele from strain R712 into strain S613 was sufficient to alter the distribution of CL domains. (e and f) Introduction of mutated gdpD and cls alleles
to S613⌬liaF177 did not produce additional alterations in the distribution of CL-rich domains. Additional images selected from different microscopic fields are
shown in Fig. S5 in the supplemental material.

that of strain R712, with most cells lacking clear polar spots and
exhibiting altered staining at the sites of cell division. Consistent
with the lack of effect of the gdpD mutation on DAP resistance (see
above), we were not able to find any substantial changes in CL
microdomain distribution in strain S613⌬gdpD170 versus strain
S613 (Fig. 3d and Fig. S6). Moreover, the pattern of NAO staining
of S613⌬liaF177gdpD170 and S613⌬liaF177gdpD170cls61 was similar to
that of S613⌬liaF177 (Fig. 3e and f), indicating that the single
LiaF⌬177 deletion was largely responsible for CL-enriched microdomain redistribution, thus establishing a link between the
LiaFSR system and changes in cell membrane PL distribution. Of
interest, the LiaFSR system of B. subtilis has been shown to mediate cell envelope responses to antimicrobial peptide attack (22). In

order to quantitate the fluorescence differences between septa and
nonseptal NAO-stained domains in DAP-resistant R712, we calculated the relative ratio of fluorescent intensity between these
sites. The relative ratio of fluorescent intensity between NAOstained domains versus septa was about 3:1, suggesting that CLenriched domains are concentrated away from the septum.
Cls and GdpD mediate changes in phospholipid content associated with DAP resistance. In order to quantitatively assess the
effects of the above gene mutations on PL content, we determined
PL content of the cell membranes of E. faecalis S613 and derivatives, as described previously (Table 2). In our earlier work, we
showed that E. faecalis strain S613 contains a large cadre of cell
membrane PL species, including several amino-containing,

TABLE 2 Cell membrane phospholipid composition and asymmetry of Enterococcus faecalis S613 and derivatives
Cell membrane PL composition (mean % ⫾ SD)a
Positively charged PLb

Negatively charged PLd
c

Strain

I-LPG

O-LPG

Total ACP

PG

CL

GP-DGDAG

PA

NegPL

S613
S613⌬liaF177gdpD170cls61
S613⌬liaF177gdpD170
S613⌬gdpD170
S613⌬liaF177

6.81 ⫾ 2.66
5.48 ⫾ 1.09
5.58 ⫾ 2.44
6.34 ⫾ 0.79
6.09 ⫾ 0.25

6.52 ⫾ 1.09
10.24 ⴞ 1.45
7.36 ⫾ 0.62
7.56 ⫾ 0.42
6.83 ⫾ 2.19

19.51 ⫾ 4.99
27.14 ⴞ 2.62
22.63 ⫾ 2.96
21.63 ⫾ 0.07
19.90 ⫾ 1.64

20.76 ⫾ 0.11
13.22 ⴞ 1.65
17.95 ⫾ 0.86
18.09 ⫾ 0.81
19.95 ⫾ 2.11

44.0 ⫾ 3.99
30.85 ⴞ 1.30
39.42 ⫾ 3.26
40.11 ⫾ 1.88
40.74 ⫾ 2.38

5.07 ⫾ 1.05
9.58 ⴞ 2.05
6.77 ⫾ 0.10
6.35 ⫾ 0.77
6.96 ⫾ 1.12

4.13 ⫾ 0.01
9.27 ⴞ 0.10
5.52 ⫾ 0.40
5.40 ⫾ 1.03
4.72 ⫾ 0.50

6.54 ⫾ 0.06
9.94 ⴞ 0.33
7.71 ⫾ 0.85
8.42 ⫾ 1.79
7.72 ⫾ 1.23

Values that are statistically significantly different (P ⬍ 0.05) from the values for strain S613 are shown in boldface type. PL, phospholipid.
LPG, lysyl-phosphatidylglycerol; I-LPG, LPG in the inner leaflet of the cell membrane; O-LPG, LPG in the outer leaflet of the cell membrane. The amount of phospholipid
flipping is determined by the difference between LPG content in the inner and outer leaflets of the cell membrane.
c ACP, amino-containing phospholipid. The amount of total ACP includes O-LPG, I-LPG, and two additional ACPs whose identity has not been established.
d Major anionic (negatively charged) phospholipid species isolated from the membrane of E. faecalis strains. PG, phosphatidylglycerol; CL, cardiolipin; GP-DGDAG,
glycerolphospho-diglycodiacylglycerol; PA, phosphatidic acid; NegPL, a negatively charged phospholipid species whose structure has not been determined.
a
b
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positively charged species, as well as the negatively charged PLs
such as PG, CL, phosphatidic acid, and glycerolphosphodiglycodiacylglycerol (GP-DPDAG) (14). As shown in Table 2,
LiaF⌬177, which reduces the DAP susceptibility of strain S613 and
is linked to changes in CL-enriched domain distribution, did not
affect actual PL content of S613 cell membranes. Similarly, no
significant changes in cell membrane PL content were identified in
the double mutant S613⌬liaF177gdpD170 compared to S613, despite
the fact that DAP MICs increased (Table 2). However, when the
liaF mutation was accompanied by changes in both gdpD and cls
(i.e., the triple mutant, S613⌬liaF177gdpD170cls61), significant alterations in cell membrane PL content were observed versus S613
including, most notably, the following: (i) a decrease in PG (ca.
40%) and CL; (ii) a compensatory increase in other negatively
charged PL species; and (iii) an increase in overall aminocontaining PLs, with substantially more “flipping” of lysylphosphatidylglycerol (L-PG) to the outer leaflet of the CM as seen
by significant changes in the amount of amino-containing PLs in
the inner versus outer CM leaflet (Table 2). These findings suggest
that Cls⌬61 (in the background of LiaF⌬177 and GdpD⌬170) is responsible for additional changes in cell membrane PL composition and asymmetry that augment and fully complete the DAP
resistance phenotype in E. faecalis. Moreover, in order to support
our findings that CL-enriched microdomain redistribution is the
main mediator of DAP resistance and is not related to global
changes in membrane structure, we stained E. faecalis S613 and
derivatives with the vital nonspecific stain FM 4-64 (23, 24) which
has been used to visualize a variety of bacterial membranes, including E. coli and B. subtilis. FM 4-64 is a non-specific lipophilic
fluorescent dye (23, 24). As shown in Fig. S8 in the supplemental
material, the membranes of S613 cells stained homogeneously
with FM 4-64, and the relative intensity of FM 4-64 fluorescence at
the septal membranes was double that of other regions of the cells,
as described previously for B. subtilis (18, 24). The FM 4-64 staining patterns of strains S613⌬liaF177 and S613⌬liaF177gdpD170
(which exhibited changes in CL-enriched microdomain redistribution) were similar to that of S613, indicating that CL redistribution was not associated with global structural changes of the
cell membrane. Conversely, heterogeneous staining of FM 4-64
was observed in R712 (wild-type DAP-resistant strain) and
S613⌬liaF177gdpD170cls61 (which exhibits changes in PL content). Indeed, intense nonseptal fluorescence spots were observed in the
latter strains (Fig. S8), suggesting that changes in phospholipid
content (but not distribution) can affect the overall membrane
structure.
DISCUSSION

Cationic antimicrobial peptides are important effectors of the innate host immune response system against bacterial infections
(25, 26), and such peptides are currently used as antibiotics in
clinical practice (e.g., DAP). Understanding the molecular mechanisms of cationic antimicrobial peptide action, as well as resistance, is likely to offer new insights into bacterial cell membrane
homeostasis and thus the possibility of discovering new targets for
antimicrobial development. Using BDP-DAP, Pogliano et al. (6)
provided novel insights into the mechanism of DAP action in
B. subtilis. Indeed, interaction of DAP with the cell membrane and
localization of BDP-DAP to the division septum appeared to be a
crucial event in the mechanism of bacterial killing by the antibiotic. Moreover, the same authors provided compelling evidence
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that proteins involved in cell division are recruited to areas where
DAP interacts with the cell membrane, a phenomenon that is
likely to affect cell division, as previously reported (12, 27). Another important aspect of DAP’s mechanism of action appears to
be its oligomerization (which seems to occur in the outer leaflet of
the cell membrane), a phenomenon that is dependent on the presence of the phospholipid PG (6, 28, 29). Using lipid vesicles and
bacterial membranes from B. subtilis, Muraih et al. (5, 29) showed
that DAP molecules interact with one another to form oligomers
on liposomal and bacterial membranes. More importantly, DAP’s
ability to oligomerize is driven by stoichiometric interactions with
PG (5, 29). Previous data originating from studies performed with
pairs of clinical strains of DAP-susceptible and DAP-resistant
S. aureus and laboratory isolates of B. subtilis (7, 22, 28) suggested
that the mechanism of DAP and antimicrobial peptide resistance
involves “repulsion” of the antibiotic molecule from the cell surface by changing the overall electrical charge of the cell envelope
(becoming more positively charged) and preventing the binding
of the antibiotic molecule with its principal target, the cell membrane. In S. aureus, several avenues have been postulated to contribute to increased cell surface charge, including an increased
amount of positively charged amino-containing phospholipids in
the outer leaflet of the cell membrane (e.g., positively charged
L-PG) mediated by the MprF enzyme (9) and enhanced alanylation of lipoteichoic acids by the Dlt proteins (30, 31). Nonetheless,
non-DAP-susceptible strains that do not appear to have changes
in cell surface charge have also been reported (32).
Our data indicate that vancomycin-resistant E. faecalis, unlike
S. aureus and B. subtilis, utilizes a distinct mechanism to overcome
the attack by calcium-decorated DAP. Using BDP-DAP, we evaluated the accumulation of the antibiotic in the cell envelope of a
pair of clinical strains of E. faecalis, a DAP-susceptible strain
(S613) and a DAP-resistant strain (R712). To our surprise, BDPDAP was not repelled from the cell surface of DAP-resistant
E. faecalis R712 (even at low concentrations), indicating that the
mechanism of resistance is not dependent on repulsion of cationic
calcium-DAP complexes from the cell envelope as previously proposed (7–9, 28). Furthermore, we provide evidence that the
amount of bound BDP-DAP is similar between R712 versus S613
at all concentrations tested, suggesting that the amount of DAP
binding is not the critical determinant of resistance but the pattern
of binding to vital structures (e.g., division septum). Our data also
suggest that the mechanism of resistance relies on diversion of the
antimicrobial peptide from the septum and provide further evidence that interactions of DAP with the septal structures are crucial for its antimicrobial activity. Our results also indicate that
saturation of the division septum by the antimicrobial peptide
molecule is concentration dependent and occurs only at concentrations of the antibiotic at or above the MIC, as has been shown
previously (6), consistent with clinical observations that higher
doses than those approved for staphylococci may have clinical
benefit against enterococci (33–35).
In order to understand the biochemical basis for DAP septal
diversion, we developed a NAO staining-based technique of enterococcal cells. NAO interacts with CL-enriched microdomains
in the cell membrane that can be visualized by fluorescence microscopy. Using NAO staining, it has been shown in E. coli and
B. subtilis that CL-enriched domains are localized at the division
septum and cell poles (15–18). Moreover, CL and other anionic
PLs have been shown to be important for the division machinery
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(21). NAO staining of E. faecalis S613 (DAP susceptible) revealed
CL-enriched domains localized at the septum and poles. However, a striking change in CL-enriched microdomain distribution
was observed in the DAP-resistant derivative R712 in which the
CL-enriched arrays were redistributed away from the division septum. This phenomenon was confirmed by calculating the relative
fluorescence intensities between septa and NAO-stained domains,
strongly suggesting that diversion of DAP from the septum is
likely to be mediated by changes in CL localization (and possibly
other anionic PLs). Moreover, we were able to show that a single
substitution in LiaF (deletion of Ile at position 177 of the putative
protein) was sufficient to affect the distribution of CL domains
without altering cell membrane PL composition. Taken together,
our data suggest that the LiaFSR system, which is predicted to
regulate the cell envelope response to antibiotics and antimicrobial peptides, is likely to mediate changes in the cell membrane by
altering PL distribution (but not content). It is also tempting to
speculate that changes in localization of PLs may also affect the
distribution of lipoteichoic acids and transmembrane proteins,
including those involved in cell wall homeostasis, affecting cell
division. Indeed, CL has been shown to affect the function of
transmembrane transporters (36, 37). Furthermore, using the vital stain FM 4-64, we also provide evidence that CL-enriched microdomain distribution is not associated with global structural
changes in the cell membrane.
Although PL redistribution was important as an initial step
toward resistance, it was not sufficient to confer clinical resistance.
Indeed, introduction of substitutions in enzymes involved in PL
metabolism (GdpD and Cls) were necessary to confer high levels
of resistance to DAP. Interestingly, introduction of Cls⌬61 into
E. faecalis S613 harboring the mutated liaF and gdpD alleles produced a striking change in PL content and DAP resistance similar
to that of E. faecalis R712, suggesting that the biochemical changes
in cell membrane composition brought about by this mutation
increased the ability of the enterococcal cell to resist the attack by
the antimicrobial peptide. Of note, we recently showed that a different substitution in Cls (R218Q) (38), which is also associated
with DAP resistance, increased the catalytic activity of the enzyme,
suggesting that changes in Cls are likely to confer a “gain-infunction” phenotype, as has been previously shown with MprF. It
is also important to note that Cls⌬61 could be introduced only
when the LiaF and GdpD substitutions were also present, suggesting that enzymatic changes in Cls may be compatible only under
specific cell membrane conditions and that changes in enzyme
activity may be deleterious unless compensatory events also occur.
On the basis of our results, a cogent model for the mechanism
of DAP resistance has emerged. In DAP-susceptible E. faecalis, cell
membrane architecture is preserved, with PG and CL constituting
the main PL species. In the absence of activation of the LiaFSR
system (wild-type LiaF), CL-enriched domains are localized at
sites of cell membrane curvature, namely the septum and poles
(similar to what has been shown in E. coli and B. subtilis). In the
presence of low concentrations of positively charged calciumbound DAP (sub-MIC), the antibiotic binds to the cell membrane, initially sparing the septum. When the concentration of
DAP increases to or above the MIC, the antibiotic accumulates at
the septum, producing alterations in cell membrane architecture
and impairment of cell division, leading to cell death. In DAPresistant E. faecalis, activation of the LiaSR two-component regulatory system results in redistribution of CL-enriched microarrays
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away from the septum. Subsequent changes in PL synthesis enzymes (such as GdpD and Cls) alter the PL composition which,
among other effects, drastically reduces PG content in the cell
membrane. Due to these changes, calcium-complexed DAP cannot effectively bind to the septum and is diverted to cell membrane
sites that, while deficient in PG, are rich in other negatively
charged PLs. Consequently, DAP is diverted to those sites but
cannot oligomerize therein, failing to fully distort cell membrane
architecture and homeostasis. Using this sophisticated strategy,
enterococci are able to survive the DAP attack. Our findings suggest a new paradigm in the mechanism of resistance to antimicrobial peptides; future studies should concentrate on dissecting the
LiaFSR response in enterococci with the intention of using this
information to develop novel antimicrobial agents that may impair the cell membrane response to daptomycin and other antibiotics.
MATERIALS AND METHODS
Bacterial strains and growth conditions. Bacterial strains and their phenotypes are listed in Table 1. Enterococcus faecalis S613 is a vancomycinresistant clinical bloodstream isolate recovered from a patient with recurrent bacteremia in 2005 (3). E. faecalis R712 is a derivative of S613,
recovered from blood from the same patient after ca. 14 days of daptomycin (DAP) and amikacin therapy (3). Strains S613⌬liaF177 and
S613⌬liaF177gdpD170 are laboratory derivatives of S613 into which the liaF
and gdpD alleles from strain R712 were introduced and have been described previously (12). Strain S613⌬liaF177gdpD170cls61, generated here,
harbors allelic replacements of liaF, gdpD. and cls (see below). Unless
otherwise noted, enterococci were cultured in brain heart infusion (BHI)
broth at 37°C with gentle agitation. DAP and boron-dipyrromethene
(BODIPY) fluorescence (FL)-labeled DAP (BDP-DAP) were provided by
Cubist Pharmaceuticals (Lexington, MA). DAP MICs were determined
on Mueller-Hinton (MH) and BHI agars by Etest (bioMérieux). DAP
MICs in trypticase soy broth (TSB) were determined by broth microdilution supplemented with Ca2⫹ (50 mg/liter). Results were interpreted
based on the breakpoints recommended by the Clinical and Laboratory
Standards Institute (CLSI) (39) on MH agar. BDP-DAP MICs were determined in Luria-Bertani (LB) broth (supplemented with Ca2⫹ [50 mg/
liter]) by microdilution with increasing concentrations of the fluorescent
antibiotic.
Mutant construction and genetic manipulations. In order to
create an E. faecalis S613 derivative harboring the mutated liaF, gdpD,
and cls alleles from E. faecalis R712, we used the p-chloro-phenylalanine
(p-Chl-Phe) sensitivity counterselection system (PheS*) (40) with
plasmid pHOU3 (which carries the chloramphenicol acetyltransferase
gene conferring resistance to chloramphenicol) as described previously
(12). Briefly, primers 5=-ATAAGAATGCGGCCGCGATGCAGCTGTTGCACGTTT (forward) and 5=-GGAATTCCGCGTATCCCGCCAATAGCC (reverse) ~500 bp upstream and downstream, respectively, of
the codon encoding position 61 of Cls were used for PCR amplifications
using the genomic DNA of strain R712 as the template. PCR products
were cloned into pHOU3 using NotI and EcoRI. The plasmid constructs
were electroporated into E. faecalis CK111 and subsequently delivered to
E. faecalis S613⌬liaF177gdpD170 by conjugation (12, 41). First, recombination integrants were selected on plates containing chloramphenicol
(15 g/ml) and vancomycin (32 g/ml). In order to obtain the desired
replacement, first-event integrants were subsequently grown on p-chlorophenylalanine, and colonies were tested by replica plating in the presence
and absence of chloramphenicol (12). Chloramphenicol-susceptible mutants were characterized by pulsed-field gel electrophoresis, and the open
reading frames of the three genes (liaF, gdpD, and cls) were sequenced in
their entirety in both directions. Growth curves of the mutant
(S613⌬liaF177gdpD170cls61) were performed in BHI and compared to the
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growth curves of strains S613, S613⌬liaF177, S613⌬liaF177gdpD177 and R712
as shown in Fig. S1 in the supplemental material.
BDP-DAP staining of E. faecalis strains. BODIPY FL-labeled daptomycin (BDP-DAP) (Cubist Pharmaceuticals) is a fluorescent derivative of
daptomycin that retains antimicrobial activity. By using fluorescence microscopy, bacterial cells can be imaged, and the sites of accumulation of
BDP-DAP in the cell membrane can be determined as previously described (6, 22, 28). Organisms were grown to exponential phase in LB
broth at 37°C with gentle shaking. One hundred microliters of each sample was incubated with BDP-DAP at increasing concentrations (2 g/ml
to 32 g/ml) in LB (supplemented with Ca2⫹ [50 mg/liter]) for 10 min in
darkness. Excess unincorporated BDP-DAP was removed by washing the
cells in LB broth three times, and the cells were immobilized on a coverslip
treated with poly-L-lysine (Sigma-Aldrich). Bacterial cells were viewed
with an Olympus IX71 microscope equipped with PlanApo N 100⫻ objective. Fluorescence was observed using a standard fluorescein isothiocyanate (FITC) filter set (excitation at 490 nm and emission at 528 nm).
Data acquisition was performed by SlideBook 5.0 software and processed
using Adobe Photoshop CS5. A minimum of two independent experiments was performed for each strain on different days. In order to estimate the amount of BDP-DAP bound to E. faecalis strain S613 versus
strain R712, we quantitated the fluorescence intensity in S613 and R712
cells treated with increasing concentrations of BDP-DAP and normalized
to protein contents of the samples. S613 and R712 cells were treated with
BDP-DAP as described above, and fluorescence was measured following
excitation at 488 nm and emission at 510 nm. Protein extraction from the
cells was performed by previously described methods (42). Protein concentrations were estimated using the bicinchoninic acid (BCA) protein
assay kit (Thermo Scientific) according to the manufacturer’s instructions.
Staining of E. faecalis strains using NAO and FM 4-64. Visualization
of cardiolipin (CL)-rich domains was performed using the fluorescent dye
10-N-nonyl acridine orange (NAO). NAO has been shown to bind preferentially to CL-enriched arrays in the cell membrane, allowing visualization of CL-enriched domains in the cell membrane (19). Association of
NAO with CL molecules results in a green-to-red shift in fluorescence
(20). For microscopic examination, cells were grown in TSB to exponential phase (A600 of ~0.3). NAO (Molecular Probes) was added to growth
medium to a final concentration of 500 nM, which did not inhibit growth
of E. faecalis. Samples were allowed to stain for 3.5 h at 37°C in darkness
with gentle shaking. After incubation, E. faecalis cells were washed three
times with 0.9% saline and immediately immobilized on a coverslip
treated with poly-L-lysine (Sigma-Aldrich). Fluorescent images were captured by an Olympus IX71 microscope with a PlanApo N 100⫻ objective.
The focus was set under phase-contrast conditions and then shifted to
light emission conditions to capture fluorescent images and minimize
photobleaching. The exposure time was 500 ms. Green fluorescence from
NAO was detected using a standard fluorescein isothiocyanate (FITC)
filter (excitation at 490 nm and emission at 528 nm). Image acquisition
was performed using the SlideBook 5.0 software package. At least three
independent sets of experiments were performed for each strain on different days. Captured images were processed using Adobe Photoshop
CS5. In a single experiment, the viability of cells was confirmed by placing
coverslips with NAO-stained bacteria on BHI agar and incubating the
coverslips at 37°C overnight. All strains grew, indicating that NAO was
not toxic to enterococci and that the images were taken while the cells
were alive. Additionally, green-to-red fluorescence shift in the images was
examined using the Nikon A1 confocal laser microscope equipped with
100⫻ Plan-Apo/1.4-numerical-aperture (NA) oil objective. Fluorescence
was viewed using the PicoQuant imaging system. Excitation was at
490 nm and emission was at either 528 or 617 nm at exposure times of 500
ms. Fluorescent areas identified at both wavelengths indicate a green-tored shift, a property exhibited by NAO when bound to cardiolipin (see
Fig. S4 in the supplemental material). Images of individual cells were used
to calculate the ratio of NAO fluorescence intensity at the division septum

8

®

mbio.asm.org

versus nonseptal NAO-stained domains in strain R712 (43, 44). Intensity
was quantitated by acquiring pixel-to-area values in the areas of interest
(ImageJ software). Three septal areas versus nonseptal domains were averaged prior to calculation of the fluorescence intensity ratio. FM 4-64
(Molecular Probes) was added to a final concentration of 1 g/ml to a cell
culture in TSB that was harvested in stationary growth phase. After incubation at 37°C for 30 min, the cells were fixed on slides coated with a layer
of 0.8% agarose gel in water. Fluorescent images were viewed using an
Olympus IX71 microscope with a PlanApo N 100⫻ objective. Red fluorescence was detected using a standard tetramethyl rhodamine isothiocyanate (TRITC) filter (excitation at 541 nm and emission at 617 nm).
Image acquisition was performed using the SlideBook 5.0 software package. At least two independent experiments were performed on different
days for each strain. Images were processed with Adobe Photoshop CS5.
Transmission electron microscopy. Transmission electron microscopy (TEM) was used to assess ultrastructural characteristics of the pair of
E. faecalis strains, strains S613 and R712, using standard methods as previously described (12). Chaining (ⱖ4 cells) was evaluated in both S613
and R712 by counting ⱖ100 cells of each isolate from different fields.
Cell membrane phospholipid composition and asymmetry. Phospholipids (PLs) were extracted from enterococcal isolates using a methodology described before (45, 46). Briefly, extraction of PLs was performed on enterococcal isolates grown in TSB for 18 h (late stationary
phase). The PLs were separated using two-dimensional thin-layer chromatography (TLC) using Silica Gel 60 F254 high-performance (HP) TLC
plates (Merck). A first dimension of chloroform⫺methanol⫺25% ammonium hydroxide (65:25:6, by volume) and a second dimension of
chloroform-water-methanol-glacial acetic acid-acetone (45:4:8:9:16, by
volume) in the vertical and horizontal orientation, respectively, were used
for the separation of the PLs (46). The identification of TLC PL spots was
made in comparison to control two-dimensional (2D) TLC plates of
known PL standards, which were purchased from Avanti Polar Lipids
(Alabaster, AL). For quantitative analysis, individual PLs from TLC plates
were digested with 0.3 ml of 70% perchloric acid (0.3 ml) at 180°C for 3 h
and then quantified spectrophotometrically at A660 (46). Experiments
were performed at least three times on separate days. Data were reported
as the mean (⫾ standard deviation [SD]).
Outer cell membrane (CM) lysyl-phosphatidylglycerol (LPG) distribution was determined using fluorescamine analysis, since this fluorophore specifically labels only surface-exposed amino-PLs in the outer CM
leaflet as described previously (7, 46). These experiments were performed
in parallel with the PL extraction and analyses described above. PL spots
on the TLC plate were confirmed by exposure to iodine vapors and spraying with CuSO4 (100 mg/ml) containing 8% phosphoric acid (vol/vol)
and heated at 180°C (47). LPG in the inner leaflet of the cell membrane
(I-LPG) (positively charged), and other amino-containing PLs were visualized by ninhydrin staining.
LC/ESI-MS/MS analysis. Major lipids separated on the 2D-TLC plate
were scraped off, extracted with chloroform, and confirmed by normalphase liquid chromatography-electrospray ionization-tandem mass spectrometry (LC/ESI-MS/MS) analysis as described before (14). Briefly,
normal-phase LC was performed on an Agilent 1200 Quaternary LC system equipped with an Ascentis Silica high-performance liquid chromatography (HPLC) column (5 m; 250 by 2.1 mm; Sigma-Aldrich, St.
Louis, MO). The mobile phases were chloroform-methanol-aqueous ammonium hydroxide (800:195:5, vol/vol) (mobile phase A solvent),
chloroform-methanol-water-aqueous ammonium hydroxide (600:340:
50:5, vol/vol) (mobile phase B solvent), and chloroform-methanol-wateraqueous ammonium hydroxide (450:450:95:5, vol/vol) (mobile phase C
solvent). The elution program consisted of the following: 100% mobile
phase A solvent was held isocratically for 2 min and then linearly increased
to 100% mobile phase B solvent over 14 min and held at 100% mobile
phase B solvent for 11 min. The LC gradient was then changed to 100%
mobile phase C solvent over 3 min, held at 100% C for 3 min, finally
returned to 100% mobile phase A solvent over 0.5 min, and held at 100%
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phase A solvent for 5 min. The total LC flow rate was 300 l/min. To
achieve optimum ESI efficiency, a postcolumn splitter was used to divert
~10% of the LC effluent into the mass spectrometer, a QSTAR XL quadrupole time-of-flight tandem mass spectrometer (Applied Biosystems,
Foster City, CA). Instrumental settings for negative ion electrospray (ESI)
and MS/MS analysis of lipid species were as follows: ion spray voltage (IS)
⫽ ⫺4,500 V; curtain gas (CUR) ⫽ 20 lb/in2; gas source–I (GSI) ⫽ 20 lb/
in2; declustering potential (DP) ⫽ ⫺55 V; and focusing potential (FP) ⫽
⫺150 V. The MS/MS analysis used nitrogen as the collision for the gas.
Data analysis was performed using Analyst QS software (Applied Biosystems, Foster City, CA).

SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at http://mbio.asm.org
/lookup/suppl/doi:10.1128/mBio.00281-13/-/DCSupplemental.
Figure S1, TIF file, 0.9 MB.
Figure S2, TIF file, 2.1 MB.
Figure S3, TIF file, 0.5 MB.
Figure S4, TIF file, 2.6 MB.
Figure S5, TIF file, 2.9 MB.
Figure S6, TIF file, 2.7 MB.
Figure S7, TIF file, 7.5 MB.
Figure S8, TIF file, 3.2 MB.

ACKNOWLEDGMENTS
C.A.A. is supported by National Institutes of Health (NIH-NIAID) grant
R01 AI093749. A.S.B. is supported by NIH-NIAID grant R01 AI39108-15,
Y.S. is supported by NIH-NIAID grant, R01 AI080714, and B.E.M. is
supported by NIH-NIAID grant, R01 AI047923. This work was also supported in part by a John S. Dunn Foundation Collaborative Research
Award.
The funding agencies had no role in study design, data collection and
analysis, decision to publish, or preparation of the manuscript.
We are grateful to Silvia Munoz-Price and John P. Quinn for providing enterococcal strains S613 and R712. We thank Joe Pogliano, Danielle
M. McGrath, Isabel Reyes, I-Hsiu Huang, and Hung Ton-That for technical support. We thank Jared A. Silverman for providing BODIPY FLlabeled daptomycin.

REFERENCES
1. Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB,
Scheld M, Spellberg B, Bartlett J. 2009. Bad bugs, no drugs: no ESKAPE!
An update from the Infectious Diseases Society of America. Clin. Infect.
Dis. 48:1–12.
2. Arias CA, Contreras GA, Murray BE. 2010. Management of multidrugresistant enterococcal infections. Clin. Microbiol. Infect. 16:555–562.
3. Munoz-Price LS, Lolans K, Quinn JP. 2005. Emergence of resistance to
daptomycin during treatment of vancomycin-resistant Enterococcus faecalis infection. Clin. Infect. Dis. 41:565–566.
4. Sabol K, Patterson JE, Lewis JS, II, Owens A, Cadena J, Jorgensen JH.
2005. Emergence of daptomycin resistance in Enterococcus faecium during
daptomycin therapy. Antimicrob. Agents Chemother. 49:1664 –1665.
5. Muraih JK, Pearson A, Silverman J, Palmer M. 2011. Oligomerization of
daptomycin on membranes. Biochim. Biophys. Acta 1808:1154 –1160.
6. Pogliano J, Pogliano N, Silverman JA. 2012. Daptomycin-mediated
reorganization of membrane architecture causes mislocalization of essential cell division proteins. J. Bacteriol. 194:4494 – 4504.
7. Jones T, Yeaman MR, Sakoulas G, Yang SJ, Proctor RA, Sahl HG,
Schrenzel J, Xiong YQ, Bayer AS. 2008. Failures in clinical treatment of
Staphylococcus aureus infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug
binding. Antimicrob. Agents Chemother. 52:269 –278.
8. Bayer AS, Schneider T, Sahl HG. 2013. Mechanisms of daptomycin
resistance in Staphylococcus aureus: role of the cell membrane and cell wall.
Ann. N. Y. Acad. Sci. 1277:139 –158.
9. Mishra NN, Yang SJ, Sawa A, Rubio A, Nast CC, Yeaman MR, Bayer
AS. 2009. Analysis of cell membrane characteristics of in vitro-selected
daptomycin-resistant strains of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 53:2312–2318.

July/August 2013 Volume 4 Issue 4 e00281-13

10. Jordan S, Hutchings MI, Mascher T. 2008. Cell envelope stress response
in Gram-positive bacteria. FEMS Microbiol. Rev. 32:107–146.
11. Munita JM, Tran TT, Diaz L, Panesso D, Reyes J, Murray BE, Arias CA.
2013. A liaF codon deletion abolishes daptomycin bactericidal activity
against vancomycin-resistant Enterococcus faecalis. Antimicrob. Agents
Chemother. 57:2831–2833.
12. Arias CA, Panesso D, McGrath DM, Qin X, Mojica MF, Miller C, Diaz
L, Tran TT, Rincon S, Barbu EM, Reyes J, Roh JH, Lobos E, Sodergren
E, Pasqualini R, Arap W, Quinn JP, Shamoo Y, Murray BE, Weinstock
GM. 2011. Genetic basis for in vivo daptomycin resistance in enterococci.
N Engl J. Med. 365:892–900.
13. Munita JM, Panesso D, Diaz L, Tran TT, Reyes J, Wanger A, Murray
BE, Arias CA. 2012. Correlation between mutations in liaFSR of Enterococcus faecium and MIC of daptomycin: revisiting daptomycin breakpoints. Antimicrob. Agents Chemother. 56:4354 – 4359.
14. Mishra NN, Bayer AS, Tran TT, Shamoo Y, Mileykovskaya E, Dowhan
W, Guan Z, Arias CA. 2012. Daptomycin resistance in enterococci is
associated with distinct alterations of cell membrane phospholipid content. PLoS One 7:e43958. doi:10.1371/journal.pone.0043958.
15. Mileykovskaya E, Dowhan W. 2000. Visualization of phospholipid domains in Escherichia coli by using the cardiolipin-specific fluorescent dye
10-N-nonyl acridine orange. J. Bacteriol. 182:1172–1175.
16. Kicia M, Janeczko N, Lewicka J, Hendrich AB. 2012. Comparison of the
effects of subinhibitory concentrations of ciprofloxacin and colistin on the
morphology of cardiolipin domains in Escherichia coli membranes. J.
Med. Microbiol. 61:520 –524.
17. Barák I, Muchová K, Wilkinson AJ, O’Toole PJ, Pavlendová N. 2008.
Lipid spirals in Bacillus subtilis and their role in cell division. Mol. Microbiol. 68:1315–1327.
18. Kawai F, Shoda M, Harashima R, Sadaie Y, Hara H, Matsumoto K.
2004. Cardiolipin domains in Bacillus subtilis marburg membranes. J. Bacteriol. 186:1475–1483.
19. Mileykovskaya E, Dowhan W, Birke RL, Zheng D, Lutterodt L, Haines
TH. 2001. Cardiolipin binds nonyl acridine orange by aggregating the dye
at exposed hydrophobic domains on bilayer surfaces. FEBS Lett. 507:
187–190.
20. Petit JM, Maftah A, Ratinaud MH, Julien R. 1992. 10N-nonyl acridine
orange interacts with cardiolipin and allows the quantification of this
phospholipid in isolated mitochondria. Eur. J. Biochem. 209:267–273.
21. Mileykovskaya E, Dowhan W. 2005. Role of membrane lipids in bacterial
division-site selection. Curr. Opin. Microbiol. 8:135–142.
22. Hachmann AB, Angert ER, Helmann JD. 2009. Genetic analysis of
factors affecting susceptibility of Bacillus subtilis to daptomycin. Antimicrob. Agents Chemother. 53:1598 –1609.
23. Fishov I, Woldringh CL. 1999. Visualization of membrane domains in
Escherichia coli. Mol. Microbiol. 32:1166 –1172.
24. Pogliano J, Osborne N, Sharp MD, Abanes-De Mello A, Perez A, Sun
YL, Pogliano K. 1999. A vital stain for studying membrane dynamics in
bacteria: a novel mechanism controlling septation during Bacillus subtilis
sporulation. Mol. Microbiol. 31:1149 –1159.
25. Ganz T. 2003. Defensins: antimicrobial peptides of innate immunity. Nat.
Rev. Immunol. 3:710 –720.
26. Zasloff M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415:389 –395.
27. Cotroneo N, Harris R, Perlmutter N, Beveridge T, Silverman JA. 2008.
Daptomycin exerts bactericidal activity without lysis of Staphylococcus aureus. Antimicrob. Agents Chemother. 52:2223–2225.
28. Hachmann AB, Sevim E, Gaballa A, Popham DL, Antelmann H, Helmann JD. 2011. Reduction in membrane phosphatidylglycerol content
leads to daptomycin resistance in Bacillus subtilis. Antimicrob. Agents
Chemother. 55:4326 – 4337.
29. Muraih JK, Harris J, Taylor SD, Palmer M. 2012. Characterization of
daptomycin oligomerization with perylene excimer fluorescence: stoichiometric binding of phosphatidylglycerol triggers oligomer formation.
Biochim. Biophys. Acta 1818:673– 678.
30. Bertsche U, Weidenmaier C, Kuehner D, Yang SJ, Baur S, Wanner S,
Francois P, Schrenzel J, Yeaman MR, Bayer AS. 2011. Correlation of
daptomycin resistance in a clinical Staphylococcus aureus strain with increased cell wall teichoic acid production and D-alanylation. Antimicrob.
Agents Chemother. 55:3922–3928.
31. Yang SJ, Kreiswirth BN, Sakoulas G, Yeaman MR, Xiong YQ, Sawa A,
Bayer AS. 2009. Enhanced expression of dltABCD is associated with the

®

mbio.asm.org 9

Tran et al.

32.

33.

34.
35.

36.
37.
38.
39.
40.

10

development of daptomycin nonsusceptibility in a clinical endocarditis
isolate of Staphylococcus aureus. J. Infect. Dis. 200:1916 –1920.
Mishra NN, Rubio A, Nast CC, Bayer AS. 2012. Differential adaptations
of methicillin-resistant Staphylococcus aureus to serial in vitro passage in
daptomycin: evolution of daptomycin resistance and role of membrane
carotenoid content and fluidity. Int. J. Microbiol. 2012:683450. doi:
10.1155/2012/683450.
Kullar R, Davis SL, Levine DP, Zhao JJ, Jr, Crank CW, Segreti J,
Sakoulas G, Cosgrove SE, Rybak MJ. 2011. High-dose daptomycin for
treatment of complicated gram-positive infections: a large, multicenter,
retrospective study. Pharmacotherapy 31:527–536.
Arias CA, Murray BE. 2012. The rise of the Enterococcus: beyond vancomycin resistance. Nat. Rev. Microbiol. 10:266 –278.
Hall AD, Steed ME, Arias CA, Murray BE, Rybak MJ. 2012. Evaluation
of standard- and high-dose daptomycin versus linezolid against vancomycinresistant Enterococcus isolates in an in vitro pharmacokinetic/
pharmacodynamic model with simulated endocardial vegetations. Antimicrob. Agents Chemother. 56:3174 –3180.
Rosch JW, Hsu FF, Caparon MG. 2007. Anionic lipids enriched at the
ExPortal of Streptococcus pyogenes. J. Bacteriol. 189:801– 806.
Vega LA, Caparon MG. 2012. Cationic antimicrobial peptides disrupt the
Streptococcus pyogenes ExPortal. Mol. Microbiol. 85:1119 –1132.
Davlieva M, Zhang W, Arias CA, Shamoo Y. 2013. Biochemical characterization of cardiolipin synthase mutations associated with daptomycin resistance in enterococci. Antimicrob. Agents Chemother. 57:289 –296.
CLSI. 2011. Performance standards for antimicrobial susceptibility
testing: twenty-first informational supplement. CLSI Document MS100S21. CLSI, Wayne, PA.
Kristich CJ, Chandler JR, Dunny GM. 2007. Development of a hostgenotype-independent counterselectable marker and a high-frequency

®

mbio.asm.org

41.

42.
43.

44.

45.
46.

47.

conjugative delivery system and their use in genetic analysis of Enterococcus faecalis. Plasmid 57:131–144.
Panesso D, Montealegre MC, Rincón S, Mojica MF, Rice LB, Singh KV,
Murray BE, Arias CA. 2011. The hylEfm gene in pHylEfm of Enterococcus
faecium is not required in pathogenesis of murine peritonitis. BMC Microbiol. 11:20. doi:10.1186/1471-2180-11-20.
Bogdanov M, Dowhan W. 1995. Phosphatidylethanolamine is required
for in vivo function of the membrane-associated lactose permease of Escherichia coli. J. Biol. Chem. 270:732–739.
Lunde CS, Rexer CH, Hartouni SR, Axt S, Benton BM. 2010. Fluorescence microscopy demonstrates enhanced targeting of telavancin to the
division septum of Staphylococcus aureus. Antimicrob. Agents Chemother. 54:2198 –2200.
Pereira PM, Filipe SR, Tomasz A, Pinho MG. 2007. Fluorescence ratio
imaging microscopy shows decreased access of vancomycin to cell wall
synthetic sites in vancomycin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 51:3627–3633.
Dixit BL, Gupta CM. 1998. Role of the actin cytoskeleton in regulating the
outer phosphatidylethanolamine levels in yeast plasma membrane. Eur. J.
Biochem. 254:202–206.
Mukhopadhyay K, Whitmire W, Xiong YQ, Molden J, Jones T, Peschel
A, Staubitz P, Adler-Moore J, McNamara PJ, Proctor RA, Yeaman MR,
Bayer AS. 2007. In vitro susceptibility of Staphylococcus aureus to
thrombin-induced platelet microbicidal protein-1 (tPMP-1) is influenced
by cell membrane phospholipid composition and asymmetry. Microbiology 153:1187–1197.
Tsai M, Ohniwa RL, Kato Y, Takeshita SL, Ohta T, Saito S, Hayashi H,
Morikawa K. 2011. Staphylococcus aureus requires cardiolipin for survival under conditions of high salinity. BMC Microbiol. 11:13. doi:
10.1186/1471-2180-11-13.

July/August 2013 Volume 4 Issue 4 e00281-13

